Octreotide Microsphere(Qilu Pharmaceutical)

醋酸奥曲肽微球 (齐鲁)

Report date: 2024/02/21 20:01:04

Base Information

Drug NameOctreotide Microsphere(Qilu Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGrowth hormone releasing factor antagonistsSomatostatin receptor agonists
TargetsSomatostatin receptorGrowth hormone releasing factor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A